{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-22-000691","form_type":"8-K","ticker":"CELZ","cik":"0001187953","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","filed_at":"2022-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.601052+00:00","generated_at":"2026-06-27T08:41:20.892125+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Creative Medical enters new 3-year employment agreements with CEO and CFO","bullets":["CEO Warbington base salary $330,000/year; CFO Dickerson $300,000/year.","Each eligible for annual cash bonus targeted at 30% of base salary.","Annual option grant valued at 30% of base salary, vesting over 3 years (25% immediate, then annual).","Severance: if terminated without cause or for good reason, 2 years of base salary plus bonuses.","Employment agreements have 3-year initial term with automatic renewal for successive 3-year periods."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-22-000691","json":"https://secwatch.observer/filing/0001477932-22-000691.json","markdown":"https://secwatch.observer/filing/0001477932-22-000691.md","text":"https://secwatch.observer/filing/0001477932-22-000691.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1187953/000147793222000691/0001477932-22-000691-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1187953/000147793222000691/celz_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T08:41:20.892125+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}